Convergence: Linking West & East, from Molecule to Product
Event Information
About this Event
In the era of innovative medicine, the Healthcare industry is facing harsh competitive business environment. Bridging west and east markets become a critical element in product success. With the theme of convergence, 2020 IQVIA JPM China Day will navigate current global pharma market environment, discuss business strategy, tactics and best practices linking west and east markets, achieving business growth and success.
MC: Kings Wang, Sr Dir, Strategic Planning & BD; Head of CS & Medical Solutions, IQVIA
9:30-9:45
Opening Remarks – Convergence Between China & US
Brian Mi, President, IQVIA GC
9:45-10:30
Market Dynamics in US & Global Market Outlook to 2024
Murray Aitken, SVP, Healthcare Insights, IQVIA
10:30-10:45
Tea break
10:45-11:30
Innovative Product Research and Development in China
Jun Bao, CEO, IMPACT Therapeutics
11:30-12:00
Sino-US Emerging Biotech’s Contribution to Global R&D Innovation
Robert Gallagher, S Principal, BIDS, IQVIA APAC
12:00-13:30 Lunch
13:30-14:00
Market Access Philosophy of Accelerated Approval Program in China
Ho Kit Chan, VP, Clinical Project Management, IQVIA GC
14:00-14:30
Go Outbound: Explore The Global Market of R&D & Commercial Strategy
Adrian McKemey, VP, Consulting, IQVIA
14:30-14:45
Tea break
14:45-15:15
Unlock China Market with Innovative Strategy & Approach
Howard Chen, Principal, Mangement Consulting, IQVIA GC
15:15-15:45
R&D innovation and commercialization: providing high quality and affordable antibody drugs for patients worldwide
Michelle Xia, Chairwoman, President and CEO, Akeso Biopharma
15:45-16:15
Panel discussion: Cross-border M&A Activities Winning Experience
Moderator: Howard Chen
Evening Reception: China Night
Venue: SLIIC Rooftop Gardens, 755 Sansome St.